Tobacco dependence treatment in patients with heart and lung disease: Implications for intervention and review of pharmacological therapy

Journal of Cardiopulmonary Rehabilitation

Volumn 20, Issue 4, 2000, Pages 215-223

  Hays, J T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONIDINE; NICOTINE; NICOTINE GUM; NORTRIPTYLINE;

BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONSTIPATION; CORONARY ARTERY DISEASE; DROWSINESS; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG MECHANISM; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; META ANALYSIS; MORBIDITY; MORTALITY; NAUSEA; PATIENT COUNSELING; RASH; REVIEW; SLEEP DISORDER; TOBACCO; TOBACCO DEPENDENCE; UNITED STATES; XEROSTOMIA;

EID: 0033855607     PISSN: 08839212     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008483-200007000-00001     Document Type: Review

References (63)

1. Actual causes of death in the United States
2. Increased levels of cigarette use among college students: A course for national concern
3. The risk of myocardial infarction after quitting smoking in men under 55 years of age
4. Decline in the risk of myocardial infarction among women who stop smoking
5. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease
6. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: The Lung Health Study
7. 1: The Lung Health Study
8. Smoking and lung function in elderly men and women: The Cardiovascular Health Study
9. The Agency for Health Care Policy and Research Smoking Cessation clinical practice guideline
10. Smoking cessation after acute myocardial infarction: Effects of a nurse-managed intervention
11. A case-management system for risk modification after acute myocardial infarction
12. Predictors of smoking cessation after coronary artery bypass graft surgery: Results of a randomized trial with 5-year follow-up
13. Smoking cessation in hospitalized patients: Results of a randomized trial
14. Efficacy of a smoking cessation program for hospital patients
15. Smoking cessation after surgery. A randomized trial
16. Smoking cessation following a cardiac rehabilitation program
17. Nicotine replacement therapy for smoking cessation
18. The effectiveness of the nicotine patch for smoking cessation: A meta-analysis
19. Recent advances in the pharmacotherapy of smoking
20. Over-the-counter nicotine patch therapy for smoking cessation: Results from randomized, double-blind, placebo-controlled and open label trials
21. The efficacy of nicotine patch as an over-the-counter medication
22. Nicotine patches in smoking cessation
23. A meta-analytic review of the efficacy of nicotine chewing gum in smoking treatment programs
24. Drinking coffee and carbonated beverages blocks absorption of nicotine from nicotine polacrilex gum
25. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation
26. The pros and cons of transdermal nicotine therapy
27. Serum nicotine and cotinine levels during nicotine patch therapy
28. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up: One-year outcome and percentage of nicotine replacement
29. Varying nicotine patch dose and type of smoking cessation counseling
30. Are higher doses of nicotine replacement more effective for smoking cessation?
31. High dose nicotine patch therapy: Percent replacement and smoking cessation with placebo 11, 22, and 44 mg/24 hour doses
32. Randomised controlled trial of nasal nicotine spray in smoking cessation
33. Effect of nicotine nasal spray on smoking cessation: A randomized, placebo-controlled, double-blind study
34. Efficacy of a nicotine nasal spray in smoking cessation: A placebo-controlled, double-blind trial
35. Nicotine nasal spray for smoking cessation: Pattern of use, side effects, relief of withdrawal symptoms and cotinine levels
36. Regional deposition of inhaled 11C-nicotine vapor in the human airways as visualized by positron emission tomography
37. A double-blind trial of a nicotine inhaler for smoking cessation
38. Efficacy of a nicotine inhaler in smoking cessation: A double-blind, placebo-controlled trial
39. The nicotine inhaler in smoking cessation
40. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs
41. A comparison of sustained-release bupropion and placebo for smoking cessation
42. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
43. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism
44. Safety profile of sustained-release bupropion in depression: Results of three clinical trials
45. A 102-center prospective study of seizure in association with bupropion
46. Combined use of nicotine patch and gum in smoking cessation: A placebo-controlled clinical trial
47. Combined use of nicotine patch and gum compared with gum alone in smoking cessation
48. Nicotine nasal spray with nicotine patch for smoking cessation: Randomised trial with six year follow up
49. Heavy smokers, smoking cessation and clonidine: Results of a double-blind, randomized trial
50. Randomized, controlled trial of clonidine for smoking cessation in a primary care setting
51. Transdermal clonidine reduces some withdrawal symptoms but did not increase smoking cessation
52. A randomized trial of nortriptyline for smoking cessation
53. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking
54. Safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease
55. Nicotine replacement therapy for patients with coronary artery disease
56. Safety of nicotine polacrilex gum used by 3094 participants in the Lung Health Study
57. Use of transdermal nicotine in a state-level prescription plan for the elderly: A first look at 'real-world' patch users
58. The emerging market for long-term nicotine maintenance
59. Harm-reduction approaches to smoking. The need for data